BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3895365)

  • 1. [Bornaprine in the treatment of parkinsonian tremor].
    Piccirilli M; D'Alessandro P; Testa A; Piccinin GL; Agostini L
    Riv Neurol; 1985; 55(1):38-45. PubMed ID: 3895365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of bornaprine on parkinsonian tremor.
    Sancesario G; Cicardi MC; Fiermonte G; Giacomini P; Stanzione P
    Ital J Neurol Sci; 1984 Sep; 5(3):289-93. PubMed ID: 6500902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bornaprine vs placebo in Parkinson disease: double-blind controlled cross-over trial in 30 patients.
    Cantello R; Riccio A; Gilli M; Delsedime M; Scarzella L; Aguggia M; Bergamasco B
    Ital J Neurol Sci; 1986 Feb; 7(1):139-43. PubMed ID: 3514543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Kr 339 in the treatment of parkinsonian tremor].
    Iivanainen M
    Duodecim; 1974; 90(8):590-6. PubMed ID: 4605767
    [No Abstract]   [Full Text] [Related]  

  • 5. [Preliminary open multicenter study on the anti-tremorigenic effectiveness of bornaprine (Sormodren)].
    Bergamasco B; Cantello R; Delsedime M; Gilli M; Riccio A; Aguggia M
    Minerva Med; 1985 Oct; 76(40):1877-81. PubMed ID: 4058785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KR 339 in the treatment of Parkinsonian tremor.
    Iivanainen M
    Acta Neurol Scand; 1974; 50(4):469-77. PubMed ID: 4604665
    [No Abstract]   [Full Text] [Related]  

  • 7. Mavoglurant (AFQ056) in combination with increased levodopa dosages in Parkinson's disease patients.
    Kumar R; Hauser RA; Mostillo J; Dronamraju N; Graf A; Merschhemke M; Kenney C
    Int J Neurosci; 2016; 126(1):20-4. PubMed ID: 24007304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.
    Stocchi F; Rascol O; Destee A; Hattori N; Hauser RA; Lang AE; Poewe W; Stacy M; Tolosa E; Gao H; Nagel J; Merschhemke M; Graf A; Kenney C; Trenkwalder C
    Mov Disord; 2013 Nov; 28(13):1838-46. PubMed ID: 23853029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacological treatment of parkinsonian tremor].
    Yokochi F
    Nihon Rinsho; 2000 Oct; 58(10):2091-5. PubMed ID: 11068452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest tremor and UPDRS part III in Parkinson's disease.
    Navan P; Findley LJ; Jeffs JA; Pearce RK; Bain PG
    Mov Disord; 2003 Feb; 18(2):176-80. PubMed ID: 12539211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin Yahr.
    Lees AJ; Tolosa E; Olanow CW
    Mov Disord; 2015 Jan; 30(1):19-36. PubMed ID: 25488030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Modification of Parkinson tremor by budipine. A comparative study with amantadine].
    Iizuka J; Fischer R
    Nervenarzt; 1986 Mar; 57(3):184-6. PubMed ID: 3515215
    [No Abstract]   [Full Text] [Related]  

  • 13. Double-blind controlled study of pergolide mesylate as an adjunct to Sinemet in the treatment of Parkinson's disease.
    Olanow CW; Alberts MJ
    Adv Neurol; 1987; 45():555-60. PubMed ID: 3548266
    [No Abstract]   [Full Text] [Related]  

  • 14. Simultaneous MAO-B and COMT inhibition in L-Dopa-treated patients with Parkinson's disease.
    Lyytinen J; Kaakkola S; Ahtila S; Tuomainen P; Teräväinen H
    Mov Disord; 1997 Jul; 12(4):497-505. PubMed ID: 9251066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Budipine in Parkinson's tremor.
    Reichmann H
    J Neurol Sci; 2006 Oct; 248(1-2):53-5. PubMed ID: 16784759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ciladopa on Parkinson's disease: a preliminary report.
    Weiner WJ; Berger JR
    Adv Neurol; 1987; 45():583-6. PubMed ID: 3548268
    [No Abstract]   [Full Text] [Related]  

  • 17. Adjuvant therapy of parkinsonian tremor.
    Koller WC; Herbster G
    Arch Neurol; 1987 Sep; 44(9):921-3. PubMed ID: 3619710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral beta-adrenergic blockade treatment of parkinsonian tremor.
    Foster NL; Newman RP; LeWitt PA; Gillespie MM; Larsen TA; Chase TN
    Ann Neurol; 1984 Oct; 16(4):505-8. PubMed ID: 6149724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind, placebo-controlled study of entacapone in levodopa-treated patients with stable Parkinson disease.
    Olanow CW; Kieburtz K; Stern M; Watts R; Langston JW; Guarnieri M; Hubble J;
    Arch Neurol; 2004 Oct; 61(10):1563-8. PubMed ID: 15477510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effectiveness and tolerance of piribedil as adjunct therapy to levodopa in patients with Parkinson's disease: a nine month follow up].
    Salazar Tortolero G; Wix Ramos R; Salazar Aladrén P; Jiménez León JC
    Rev Neurol; 2004 Apr 16-30; 38(8):715-9. PubMed ID: 15122540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.